Mueller T, Thompson G K, Schröder R. "一种的合成方法" [P]. US Patent, US 9504760 B2, 2024-09-10.
发明人沈红梅,徐明华,周伟. "Method for the Synthesis of 3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-5-[(E)-2-{[4-(propan-2-yl)phenyl]amino}ethenyl]-1,2-thiazole-4-carbonitrile" [P]. 中国发明专利, 专利号 CN 112842729 B, 授权公告日 2022-06-03.
Chen K W, Davis P L, Brown S R. "A Process for Preparing High-Purity 3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-5-[(E)-2-{[4-(propan-2-yl)phenyl]amino}ethenyl]-1,2-thiazole-4-carbonitrile" [P]. US Patent, US 10832774 B2, 2018-12-18.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2019, 584, 6264-6275.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2012, 570, 9321-9339.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-5-[(E)-2-{[4-(propan-2-yl)phenyl]amino}ethenyl]-1,2-thiazole-4-carbonitrile Using HRMS and NMR". J. Pharm. Biomed. Anal., 2019, 1623, 4272-4282.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2017, 842, (11), 417-436.